Company Encyclopedia
View More
name
CornerCap Fundametrics Large-Cap ETF
FUNL.US
News
View More

High-Yield Brookfield Renewable Is Building the Real Backbone of the AI Revolution

Brookfield Renewable, controlled by Brookfield Asset Management, is a high-yield investment opportunity linked to AI's power needs. Offering a partnership yield of 5.3% and a corporate yield of 3.7%, it attracts income-focused investors. Brookfield Renewable's clean energy portfolio supports AI giants like Microsoft and Google, making it a diversified, global player in solar, wind, storage, hydroelectric, and nuclear power. It's a solid investment for those seeking high yields and involvement in AI's infrastructure without direct tech stock exposure.

Motley Fool·
US
GOOGL
-0.63%
US
BEPC
+1.37%
US
MSFT
+0.65%
Motley Fool·
US
GOOGL
-0.63%
US
BEPC
+1.37%
US
MSFT
+0.65%

'It's Not a Close Fight Anymore,'Says Top Analyst About Alphabet Stock

Top analyst Michael Levine from Pivotal Research has raised Alphabet's (GOOGL) price target to $400, indicating a 26% upside. Levine highlights Alphabet's strong AI system, Gemini, and its strategic advantages over rivals. He believes Alphabet's revenue, profits, and free cash flow will continue to improve. Wall Street maintains a Strong Buy consensus on Alphabet stock.

Tip Ranks·
US
GOOG
-0.70%
US
GOOGL
-0.63%
US
GGLS
+0.60%
Tip Ranks·
US
GOOG
-0.70%
US
GOOGL
-0.63%
US
GGLS
+0.60%

M Holdings Securities Inc. Increases Holdings in AbbVie Inc. $ABBV

M Holdings Securities Inc. increased its holdings in AbbVie Inc. by 68.6% in Q2, owning 16,979 shares worth $3,121,000. Several other institutional investors also adjusted their positions in AbbVie. Analysts have upgraded AbbVie's stock ratings, with a current average rating of "Moderate Buy" and a target price of $241.85. AbbVie reported Q3 earnings of $1.86 EPS, beating estimates, and increased its quarterly dividend to $1.73 per share. The company has a market cap of $404.17 billion.

Market Beat·
US
ABBV
-0.66%
Market Beat·
US
ABBV
-0.66%

Marshall Wace LLP Increases Stock Position in Lam Research Corporation $LRCX

Marshall Wace LLP increased its holdings in Lam Research Corporation by 77.5% in Q2, owning 1,502,100 shares worth $146.2 million. Other investors like Epoch Investment Partners and Baird Financial Group also boosted their stakes. Insider sales included Director Bethany Mayer and SVP Vahid Vahedi. Lam Research reported Q2 earnings of $1.26 per share, beating estimates, with revenue up 27.7% year-over-year. The company announced a quarterly dividend payable on January 7th.

Market Beat·
US
LRCX
-1.67%
Market Beat·
US
LRCX
-1.67%

Mirabella Financial Services LLP Has $2.41 Million Position in AbbVie Inc. $ABBV

Mirabella Financial Services LLP reduced its stake in AbbVie Inc. by 69.5% in Q2, owning 12,919 shares worth $2.41 million. Other institutional investors adjusted their positions in AbbVie. Analysts have varied ratings, with a consensus of "Moderate Buy" and a target price of $241.85. AbbVie reported Q3 earnings of $1.86 EPS, beating estimates, and increased its dividend to $1.73 per share. The stock opened at $228.68, with a market cap of $404.17 billion.

Market Beat·
US
ABBV
-0.66%
Market Beat·
US
ABBV
-0.66%
© 2025 Longbridge｜Disclaimer